학술논문
HALT-D: a randomized open-label phase II study of crofelemer for the prevention of chemotherapy-induced diarrhea in patients with HER2-positive breast cancer receiving trastuzumab, pertuzumab, and a taxane
Document Type
Article
Author
Source
In: Breast Cancer Research and Treatment . (Breast Cancer Research and Treatment, December 2022, 196(3):571-581)
Subject
Language
English
ISSN
15737217
01676806
01676806